Literature DB >> 24487422

Morning melatonin serum values do not correlate with disease activity in rheumatoid arthritis: a cross-sectional study.

Mozhgan Afkhamizadeh1, Maryam Sahebari, Seyyed-Reza Seyyed-Hoseini.   

Abstract

Rheumatoid arthritis (RA), the most prevalent autoimmune arthritis worldwide, usually presents with a circannual manner and, meanwhile, follows a circadian rhythm for symptoms like morning stiffness. Therefore, association between RA and some hormones such as melatonin (MLT) and vitamin D, whose serum values are related to body circadian rhythms or seasonal variations, has become more noticeable recently. Since some studies proposed that RA patients show altered MLT circadian rhythms, especially in concordance with symptoms, in this research, we present the correlation between MLT serum values and RA disease activity score (DAS28ESR). The current cross-sectional study was carried out on 80 volunteers (60 patients and 20 healthy controls). Fifty percent of the participants in each group were sampled in cold, and the same percentage were sampled in warm seasons at 8 a.m. Disease activity was estimated utilizing DAS28ESR. Patients with possible known confounders of MLT secretion were excluded. A commercial MLT ELISA kit was employed to measure MLT. Statistical analysis was conducted by SPSS-11 software. This study outlined higher serum values of MLT in RA patients compared with controls (P = 0.006, z = -2.73). However, MLT did not correlate with DAS in patients (P = 0.45, r = -0.09). GLM analysis demonstrated that DAS28ESR, age, disease duration, medications, gender, and season of sampling had no influence on serum MLT. However, newly diagnosed RA patients presented higher MLT values than established ones (P = 0.03, t = -2.2). A cutoff point value of 23 pg/mL (63.3 % sensitivity and 90 % specificity) for MLT was computed between patients and controls. This study denoted that morning MLT serum values are higher in RA patients than in healthy volunteers. However, MLT and RA disease activity or other disease characteristics do not correlate. MLT serum values were higher in newly diagnosed RA patients than established ones.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24487422     DOI: 10.1007/s00296-013-2930-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

Review 1.  Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management.

Authors:  Rainer H Straub; Maurizio Cutolo
Journal:  Arthritis Rheum       Date:  2007-02

2.  Melatonin treatment does not improve rheumatoid arthritis.

Authors:  Georges J Maestroni; Kati Otsa; Maurizio Cutolo
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

3.  Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans.

Authors:  K P Wright; P Badia; B L Myers; S C Plenzler; M Hakel
Journal:  Brain Res       Date:  1997-01-30       Impact factor: 3.252

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  Alterations in nocturnal serum melatonin levels in humans with growth and aging.

Authors:  F Waldhauser; G Weiszenbacher; E Tatzer; B Gisinger; M Waldhauser; M Schemper; H Frisch
Journal:  J Clin Endocrinol Metab       Date:  1988-03       Impact factor: 5.958

6.  Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison.

Authors:  M Cutolo; G J M Maestroni; K Otsa; O Aakre; B Villaggio; S Capellino; P Montagna; L Fazzuoli; T Veldi; T Peets; E Hertens; A Sulli
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

7.  Effects of indirect light and propranolol on melatonin levels in normal human subjects.

Authors:  A Mayeda; S Mannon; J Hofstetter; M Adkins; R Baker; K Hu; J Nurnberger
Journal:  Psychiatry Res       Date:  1998-10-19       Impact factor: 3.222

8.  Melatonin serum levels in rheumatoid arthritis.

Authors:  A Sulli; G J M Maestroni; B Villaggio; E Hertens; C Craviotto; C Pizzorni; M Briata; B Seriolo; M Cutolo
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

9.  Serum melatonin in juvenile rheumatoid arthritis: correlation with disease activity.

Authors:  Hanaa Mahmoud El-Awady; Amany Salah El-Dien El-Wakkad; Maysa Tawheed Saleh; Saadia Ibraheem Muhammad; Eiman Mahmoud Ghaniema
Journal:  Pak J Biol Sci       Date:  2007-05-01

10.  Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin.

Authors:  Caroline M Forrest; Gillian M Mackay; Nicholas Stoy; Trevor W Stone; L Gail Darlington
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

View more
  5 in total

1.  Can the morning serum melatonin values reflect inflammatory activity: a biochemical evaluation?

Authors:  Ibrahim Aydin
Journal:  Rheumatol Int       Date:  2014-03-17       Impact factor: 2.631

Review 2.  Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  Kohsuke Yoshida; Teppei Hashimoto; Yoshitada Sakai; Akira Hashiramoto
Journal:  J Immunol Res       Date:  2014-05-08       Impact factor: 4.818

Review 3.  Melatonin in Chronic Pain Syndromes.

Authors:  Andrei Danilov; Julia Kurganova
Journal:  Pain Ther       Date:  2016-03-16

Review 4.  Reconsidering the Role of Melatonin in Rheumatoid Arthritis.

Authors:  Iona J MacDonald; Chien-Chung Huang; Shan-Chi Liu; Chih-Hsin Tang
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

Review 5.  Amino Acid Metabolism in Rheumatoid Arthritis: Friend or Foe?

Authors:  Eleonora Panfili; Roberto Gerli; Ursula Grohmann; Maria Teresa Pallotta
Journal:  Biomolecules       Date:  2020-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.